En español

Menu

Publications

Quick Links

COVID-19 is an emerging, rapidly evolving situation.


Get the latest information from CDC (coronavirus.gov) | NIH Resources | NIDA Resources

NIDA Notes Articles: Treatment Research

NIDA Notes Category Graphic

Many People Treated for Opioid Overdose in Emergency Departments Die Within 1 Year

April 2020
About 1 in 20 patients treated for a nonfatal opioid overdose in an emergency department died within 1 year of their visit, many within 2 days. Two-thirds of these deaths were directly attributed to subsequent opioid-related overdoses.

NIDA Notes Category Graphic

Serotonin Receptor Agonist Lorcaserin Reduces Relapse to Drug Use in Monkeys

March 2020
The serotonin 2C receptor agonist lorcaserin reduced reinstatement of drug-seeking behavior in response to heroin or cocaine in a nonhuman primate model of relapse.

NIDA Notes Category Graphic

Antiretroviral Therapy Combined With CRISPR Gene Editing Can Eliminate HIV Infection in Mice

February 2020
This study found that HIV-1 could be eliminated in mice using a combination of two antiviral technologies—long-acting viral reservoir–targeted antiretroviral therapy and CRISPR/Cas-9 gene editing. HIV was undetectable in 9 out of 23 mice that received the combination treatment. HIV was not eliminated in any of the mice that were given either treatment alone.

NIDA Notes Category Graphic

Part 2: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

February 2020
Researchers move their monoclonal antibody (mAb) into clinical trials to see if it can be an effective treatment for methamphetamine use.

NIDA Notes Category Graphic

Part 1: Immunotherapies—A New Tool To Treat Methamphetamine Addiction?

January 2020
Researchers have created a monoclonal antibody (mAb) that is intended to interact with methamphetamine and decrease its ability to enter the brain.

NIDA Notes Category Graphic

AOUD Treatment in Primary Care Settings—Is it Feasible?

January 2020
Treatment for alcohol and opioid use disorders (AOUD) is feasible in primary care settings, but ongoing funding to support organizational capacity is critical for sustaining such programs.

NIDA Notes Category Graphic

Novel Dopamine D3 Receptor Antagonist Reduces Opioid Addiction-Like Behaviors in Rats

January 2020
The dopamine D3 receptor antagonist VK4-116 reduced oxycodone self-administration in rats, as well as drug-seeking behaviors after oxycodone reinstatement following withdrawal. VK4-116 did not interfere with oxycodone’s pain-relieving effects

NIDA Notes Category Graphic

α2δ-1–NMDA Receptor Interactions Are Responsible for Increases in Pain Sensitivity Caused by Opioids

December 2019
In animal studies, α2δ-1 and its interactions with NMDA receptors in the spinal cord triggered the pain sensitivity and analgesic tolerance that occurs with chronic morphine treatment. Blocking the α2δ-1–NMDA interaction reduced opioid-induced hyperalgesia and analgesic tolerance.

NIDA Notes Category Graphic

Mindful Awareness in Body-Oriented Therapy Proves Useful in Women Treated for Substance Use Disorder

October 2019
Mindful Awareness in Body-Oriented Therapy (MABT) improved emotion regulation, reduced craving, and promoted abstinence in women with a history of trauma and emotional problems receiving outpatient treatment for substance use disorder.

NIDA Notes Category Graphic

Machine Learning Applied to Brain Imaging Data Predicts Response to Cocaine Use Disorder Treatment

October 2019
This study demonstrated that functional connectivity among a large number of brain regions predicts patients’ chances of achieving abstinence in treatment for cocaine use disorder.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics